NCT03387176View on ClinicalTrials.gov

Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

June 14, 2021

Study Completion Date

June 14, 2021

Conditions
Nephrotic Syndrome
Interventions
OTHER

Implementation of a gluten-free diet

Patients will be placed on gluten free diet for 9-12 months.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03387176 - Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker | Biotech Hunter | Biotech Hunter